Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $662,108 - $789,628
16,561 New
16,561 $754,000
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $1.03 Million - $1.19 Million
-13,346 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $725,715 - $848,533
-9,732 Reduced 42.17%
13,346 $1.15 Million
Q3 2021

Oct 28, 2021

SELL
$73.77 - $83.61 $210,096 - $238,121
-2,848 Reduced 10.99%
23,078 $1.86 Million
Q2 2021

Aug 10, 2021

BUY
$80.5 - $88.01 $2.09 Million - $2.28 Million
25,926 New
25,926 $2.09 Million
Q4 2019

Feb 13, 2020

SELL
$76.7 - $88.45 $2.23 Million - $2.58 Million
-29,130 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$81.4 - $89.78 $342,042 - $377,255
4,202 Added 16.86%
29,130 $2.55 Million
Q2 2019

Jul 08, 2019

BUY
$73.44 - $82.41 $1.36 Million - $1.53 Million
18,585 Added 293.0%
24,928 $2.04 Million
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $137,858 - $173,840
-2,138 Reduced 25.21%
6,343 $516,000
Q4 2018

Feb 05, 2019

BUY
$61.45 - $77.8 $358,192 - $453,496
5,829 Added 219.8%
8,481 $558,000
Q3 2018

Nov 02, 2018

SELL
$70.71 - $77.75 $889,602 - $978,172
-12,581 Reduced 82.59%
2,652 $0
Q2 2018

Aug 20, 2018

BUY
$63.43 - $75.41 $468,367 - $556,827
7,384 Added 94.08%
15,233 $0
Q1 2018

May 21, 2018

SELL
$62.56 - $72.26 $54,614 - $63,082
-873 Reduced 10.01%
7,849 $0
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $2.6 Million - $2.79 Million
-42,254 Reduced 82.89%
8,722 $564,000
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $294,822 - $320,142
4,955 Added 10.77%
50,976 $3.2 Million
Q2 2017

Aug 17, 2017

BUY
N/A
46,021
46,021 $2.79 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.